iTech Medical, Inc. today issued a correction relating to the sale of shares in Relevium Technologies Inc. (TSX VENTURE:RLV) (FRANKFURT:6BX) ("Relevium").

TORONTO, ONTARIO, CANADA, November 16, 2017 /EINPresswire.com/ -- iTech Medical, Inc. (“iTech” or the “Company”) today issued a correction relating to the sale of shares in Relevium Technologies Inc. (TSX VENTURE:RLV) (FRANKFURT:6BX) ("Relevium"). In a transaction report filed on the System for Electronic Disclosure for Insiders (SEDI), dated October 31, 2017, iTech reported the sale of 500,000 shares of Relevium at a price of CDN$0.07. iTech today reported that the sale of shares was completed in a private transaction on April 29, 2016.

“We regret any confusion our filing may have caused,” said Wayne Cockburn, CEO of iTech. “iTech remains strongly committed to the success of the Relevium business, its Management and the Board of Directors. As long-term participants in the Life Sciences Industry, iTech has a clear understanding and appreciation for Relevium’s strategic focus on building e-retail brands, products and technologies in the health and wellness market”.

About iTech Medical

iTech Medical, Inc. is a private company that develops and markets innovative medical devices and technologies.

Wayne Cockburn
iTech Medical, Inc.
905-505-0770
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.